Multiple Biomarker Approach to Risk Stratification in COVID-19.

Smilowitz, Nathaniel R; Nguy, Vuthy; Aphinyanaphongs, Yindalon; Newman, Jonathan D; Xia, Yuhe; Reynolds, Harmony R; Hochman, Judith S; Fishman, Glenn I et al. · Circulation · 2021

Where this comes from

Abstract

A multiple biomarker strategy using CRP, D-dimer and troponin identifies COVID-19 patients at risk for in-hospital adverse events.

Medical subject headings